Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Aurobindo Faulted In US FDA Warning Letter For Poor Root Cause Investigations
Jul 03 2019
•
By
Bowman Cox
fda warns aurobindo about solvent-related impurities and more
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance